Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) — Cash Flow Quality Index
Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a Cash Flow Quality Index of 9.57x as of September 2025. Operating cash flow of CN¥112.57 Million exceeds net income of CN¥11.76 Million, indicating high earnings quality where cash backs reported profits. Explore 002940 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Zhejiang Anglikang Pharmaceutical Co Ltd Class A across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002940 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Year-by-year earnings quality comparison for Zhejiang Anglikang Pharmaceutical Co Ltd Class A. For live market cap and the full company financial profile, see Zhejiang Anglikang Pharmaceutical Co Ltd (002940) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.95x | CN¥244.13 Million | CN¥125.44 Million | ▲ +16.6% |
| 2024 | 1.67x | CN¥253.60 Million | CN¥151.89 Million | ▲ +10.4% |
| 2023 | 1.51x | CN¥276.91 Million | CN¥183.06 Million | ▲ +8.1% |
| 2022 | 1.40x | CN¥184.75 Million | CN¥131.99 Million | ▲ +0.1% |
| 2021 | 1.40x | CN¥197.65 Million | CN¥141.32 Million | ▲ +27.7% |
| 2020 | 1.10x | CN¥198.61 Million | CN¥181.30 Million | ▼ -35.1% |
| 2019 | 1.69x | CN¥213.49 Million | CN¥126.46 Million | ▲ +53.7% |
| 2018 | 1.10x | CN¥133.61 Million | CN¥121.67 Million | ▼ -40.2% |
| 2017 | 1.84x | CN¥193.77 Million | CN¥105.43 Million | ▲ +4.9% |
| 2016 | 1.75x | CN¥141.74 Million | CN¥80.93 Million | ▼ -26.6% |
| 2015 | 2.39x | CN¥138.59 Million | CN¥58.10 Million | ▲ +96.2% |
| 2014 | 1.22x | CN¥50.46 Million | CN¥41.51 Million | — |